186 related articles for article (PubMed ID: 34902266)
21. Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of
Kebriaei R; Rice SA; Stamper KC; Rybak MJ
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670436
[TBL] [Abstract][Full Text] [Related]
22. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
[TBL] [Abstract][Full Text] [Related]
23. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
Ghahremani M; Jazani NH; Sharifi Y
J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
[TBL] [Abstract][Full Text] [Related]
24. Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure.
Lenhard JR; Brown T; Rybak MJ; Meaney CJ; Norgard NB; Bulman ZP; Brazeau DA; Gill SR; Tsuji BT
Antimicrob Agents Chemother; 2015 Dec; 60(3):1584-91. PubMed ID: 26711763
[TBL] [Abstract][Full Text] [Related]
25. Nemonoxacin has potent activity against gram-positive, but not gram-negative clinical isolates.
Li ZX; Liu YN; Wang R; Li AM
Clin Ter; 2015; 166(6):e374-80. PubMed ID: 26794819
[TBL] [Abstract][Full Text] [Related]
26. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
[TBL] [Abstract][Full Text] [Related]
27. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
LaPlante KL; Woodmansee S
Antimicrob Agents Chemother; 2009 Sep; 53(9):3880-6. PubMed ID: 19564363
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
[TBL] [Abstract][Full Text] [Related]
29. Activity of pulmonary vancomycin exposures versus planktonic and biofilm isolates of methicillin-resistant Staphylococcus aureus from cystic fibrosis sputum.
Britt NS; Hazlett DS; Horvat RT; Liesman RM; Steed ME
Int J Antimicrob Agents; 2020 Apr; 55(4):105898. PubMed ID: 31931147
[TBL] [Abstract][Full Text] [Related]
30. Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India.
Bakthavatchalam YD; Babu P; Munusamy E; Dwarakanathan HT; Rupali P; Zervos M; John Victor P; Veeraraghavan B
PLoS One; 2019; 14(12):e0227009. PubMed ID: 31887179
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia.
Harigaya Y; Bulitta JB; Forrest A; Sakoulas G; Lesse AJ; Mylotte JM; Tsuji BT
Antimicrob Agents Chemother; 2009 Sep; 53(9):3894-901. PubMed ID: 19596879
[TBL] [Abstract][Full Text] [Related]
32. Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.
Sancak B; Yagci S; Gür D; Gülay Z; Ogunc D; Söyletir G; Yalcin AN; Dündar DO; Topçu AW; Aksit F; Usluer G; Ozakin C; Akalin H; Hayran M; Korten V
BMC Infect Dis; 2013 Dec; 13():583. PubMed ID: 24325260
[TBL] [Abstract][Full Text] [Related]
33.
Mohammadi-Berenjestanaki H; Khori V; Shirzad-Aski H; Ghaemi EA
Microb Drug Resist; 2020 Mar; 26(3):218-226. PubMed ID: 31424323
[
